Skip to main content
ImmuneCited

N-Acetylcysteine 用于 Acute Bronchitis

B

Meta-analyses associate NAC supplementation with lower inflammatory markers and improved oxygenation in respiratory patients. Its well-established mucolytic properties support airway clearance in acute bronchitis. NAC is an FDA-approved mucolytic agent with a long safety record.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dnac\u0026condition\u003Dacute\u002Dbronchitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

结论

Meta-analyses associate NAC supplementation with lower inflammatory markers and improved oxygenation in respiratory patients. Its well-established mucolytic properties support airway clearance in acute bronchitis. NAC is an FDA-approved mucolytic agent with a long safety record.

Key Study Findings

Review
N-acetylcysteine in paediatrics: a review of efficacy, safety and dosing strategies in respiratory care.
Dose: 20 mg/kg/day acute; 200 mg TID chronic vs: None Outcome: Efficacy in pediatric respiratory diseases 效果: None None

研究人群: Children with acute/chronic respiratory diseases

Other n=270 8 weeks
N-acetyl-L-cysteine and lauric acid; effective antioxidant and antimicrobial feed additives for juvenile Pacific white shrimp …
Dose: 0.2% supplementation vs: Control diet at LSD and HSD Outcome: Growth, immune and antioxidant response in shrimp 效果: None None

研究人群: Pacific white shrimp (L. vannamei) at high stocking density

In Vitro
Improving in vitro induction efficiency of human primordial germ cell-like cells using N2B27 or NAC-based …
Dose: None vs: GK15 induction without NAC Outcome: hPGCLC induction efficiency 效果: None None

研究人群: Human iPSCs (in vitro)

Review
Cautious Hope for Cannabidiol (CBD) in Rheumatology Care.
Dose: Cannabidiol (CBD) vs: None Outcome: Pain and inflammation in rheumatic diseases 效果: None None

研究人群: Patients with rheumatic diseases

Randomized Controlled Trial n=333 1.0 weeks Double-blind
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion.
Dose: 600 mg vs: placebo and ambroxol Outcome: Sputum viscosity and expectoration difficulty 效果: None p<0.001

研究人群: Patients with respiratory disease and abnormal mucus

animal study (controlled experiment) n=120 3 weeks
Effects of N-acetyl-l-cysteine on chronic heat stress-induced oxidative stress and inflammation in the ovaries of …
Dose: 1 g/kg NAC in basal diet vs: Placebo 效果: None None

Key Statistics

10

研究数量

1500

受试者

Positive

B

等级

Referenced Papers

Arthritis care & … 2023 36 次引用
Phytomedicine : international … 2008 100 次引用
Cardiovascular research 2006 42 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
600-1,200 mg/day
respiratorysupport:
600 mg 2-3x/day

上限: No established UL; doses up to 1,800 mg/day widely studied

研究中使用的剂量

剂量 持续时间 效果 N
20 mg/kg/day acute; 200 mg TID chronic -- Positive --
0.2% supplementation 8 weeks Positive 270
None -- Positive --
Cannabidiol (CBD) -- Mixed --
600 mg 1.0 weeks Mixed 333
1 g/kg NAC in basal diet 3 weeks Positive 120
None -- Mixed --
1000 mg/kg in basal diet 3 weeks Positive 120

最佳服用时间: Between meals on empty stomach for optimal absorption

Safety & Side Effects

已报告的副作用

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Unpleasant sulfur taste/smell
  • Headache
  • Rare: bronchospasm (in asthma patients, inhaled form)

已知相互作用

  • Nitroglycerin (may enhance vasodilatory and headache effects)
  • Activated charcoal (reduces NAC absorption)
  • Anticoagulants (theoretical effect on platelet function)

可耐受最高摄入量: No established UL; doses up to 1,800 mg/day widely studied

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does N-Acetylcysteine help with Acute Bronchitis?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that N-Acetylcysteine may support Acute Bronchitis management. Our evidence grade is B (Good Evidence).
How much N-Acetylcysteine should I take for Acute Bronchitis?
Studies have used various dosages. A commonly studied range is 600-1,200 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of N-Acetylcysteine?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Unpleasant sulfur taste/smell, Headache, Rare: bronchospasm (in asthma patients, inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for N-Acetylcysteine and Acute Bronchitis?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

其他成分用于 Acute Bronchitis

N-Acetylcysteine 用于其他健康状况

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。